Pretalli Jean-Baptiste, Vernerey Dewi, Evrard Philippe, Pozet Astrid, Clairet Anne-Laure, Benoist Stéphane, Karoui Mehdi, Cotte Eddy, Heyd Bruno, Lakkis Zaher
Department of Digestive Surgical Oncology-Liver Transplantation Unit, University Hospital of Besançon, Besançon, France.
INSERM CIC 1431, Centre d'Investigation Clinique, University Hospital of Besançon, Besançon, France.
Colorectal Dis. 2025 May;27(5):e70119. doi: 10.1111/codi.70119.
Anastomotic leak (AL) is a major problem in colorectal surgery, and its prevention is crucial for patient safety. The scientific literature shows that optimal anastomotic perfusion is essential for anastomotic healing. However, in cases of left colon or rectal cancer requiring high vessel ligation for oncological reasons, anastomotic blood supply relies mainly on the pericolic arterial arcades. Consequently, assessing anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green might be relevant to reduce the risk of AL. Although evidence of its positive impact on the risk of AL is growing in the literature, most studies are descriptive prospective cohorts or retrospective comparative series with controversial findings. Furthermore, no other studies specifically address left-sided colon or high rectal tumours. FLUOCOL-1 is a large multicentre randomized controlled trial (RCT) that aims to demonstrate that assessing anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green will reduce ALs in left-sided or high anterior resections with intraperitoneal anastomosis METHOD: FLUOCOL-1 is a French multicentre, single-blind, randomized, two-arm, phase III superiority clinical trial. Patients will be randomized in a 1:1 ratio to either the intervention group (FLUO+) or the control group (FLUO-). A total of 1010 patients will be randomized. The primary endpoint is the occurrence of an AL within 90 days postsurgery. AL is defined as any anastomotic dehiscence with leakage into the pelvic cavity diagnosed by imaging or surgical exploration, or any isolated pelvic organ-space infection with no evidence of fistula, as defined by the International Study Group of Rectal Cancer.
Prevention of AL is one of the most important questions to be addressed in colorectal surgery. The FLUOCOL-1 multicentre RCT described herein aims to demonstrate that assessment of anastomotic perfusion using intraoperative fluorescence angiography with indocyanine green will reduce ALs in certain resections with intraperitoneal anastomosis.
吻合口漏是结直肠手术中的一个主要问题,其预防对患者安全至关重要。科学文献表明,最佳的吻合口灌注对吻合口愈合至关重要。然而,在因肿瘤原因需要高位血管结扎的左半结肠癌或直肠癌病例中,吻合口血供主要依赖于结肠旁动脉弓。因此,使用吲哚菁绿术中荧光血管造影评估吻合口灌注可能有助于降低吻合口漏的风险。尽管其对吻合口漏风险的积极影响在文献中的证据越来越多,但大多数研究是描述性前瞻性队列或回顾性比较系列,结果存在争议。此外,没有其他研究专门针对左侧结肠癌或高位直肠肿瘤。FLUOCOL-1是一项大型多中心随机对照试验(RCT),旨在证明使用吲哚菁绿术中荧光血管造影评估吻合口灌注将减少左侧或高位前切除术并进行腹腔内吻合时的吻合口漏。
FLUOCOL-1是一项法国多中心、单盲、随机、双臂、III期优效性临床试验。患者将按1:1的比例随机分为干预组(FLUO+)或对照组(FLUO-)。总共将有1010名患者被随机分组。主要终点是术后90天内发生吻合口漏。吻合口漏定义为通过影像学或手术探查诊断为吻合口裂开并漏入盆腔,或国际直肠癌研究组定义的任何无瘘证据的孤立盆腔器官间隙感染。
预防吻合口漏是结直肠手术中要解决的最重要问题之一。本文所述的FLUOCOL-1多中心RCT旨在证明使用吲哚菁绿术中荧光血管造影评估吻合口灌注将减少某些腹腔内吻合切除术时的吻合口漏。